Deutsch English Français

Contact

EP1776383

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1776383

EP1776383 - BINDING MOLECULES [Right-click to bookmark this link]
Status	Patent revoked Status updated on 11.02.2022 Database last updated on 03.04.2025
Former	The patent has been granted Status updated on 21.12.2016
Most recent event Tooltip	11.02.2022	Revocation of patent	published on 16.03.2022 [2022/11]
Applicant(s)	For all designated states Erasmus University Medical Center Rotterdam Department of Cell Biology and Genetics P.O.Box 1738 3000 DR Rotterdam / NL
	For all designated states Craig, Roger Kingdon Jubilee House Farm, Spen Moss, Smallwood Sandbach, Cheshire CW11 2XB / GB
	[2014/34]
Former [2007/39]	For all designated states Erasmus University Medical Center Rotterdam Department of Cell Biology and Genetics, P.O.Box 1738 3000 DR Rotterdam / NL
	For all designated states Craig, Roger Kingdon Jubilee Hose Farm, Spen Moss, Smallwood Sandbach, Cheshire CW11 2XB / GB
Former [2007/17]	For all designated states Erasmus University Medical Center Faculty of Medicine Dept. of Cell Biology and Genetics P.O. Box 1738 3000 DR Rotterdam / NL
	For all designated states Craig, Roger Kingdon Jubilee Hose Farm, Spen Moss, Smallwood Sandbach, Cheshire CW11 2XB / GB
Inventor(s)	01 / GROSVELD, Franklin G.@Erasmus Univ. Med.Ctr.R'Dam Dept. of Cell Biology & Genetics P.O Box 1738 NL-3000 DR Rotterdam / NL
	02 / JANSSENS, Richard W.@Erasmus Univ. Med.Ctr. R'Dam Dept. of Cell Biology & Genetics P.O. Box 1738 NL-3000 DR Rotterdam / NL
	03 / DRABEK, Dubravka@Erasmus Univ. Med. Ctr. R'Dam Dept. of Cell Biology & Genetics P.O. Box 1738 NL-3000 DR Rotterdam / NL
	04 / CRAIG, Roger, Kingdon Jubilee House Farm, Spen Moss Smallwood Sandbach, Cheshire CW11 2XB / GB
	[2014/34]
Former [2007/17]	01 / GROSVELD, Franklin G. Erasmus Univ. Med.Ctr.R'Dam Dept. of Cell Biology & Genetics P.O Box 1738 NL-3000 DR Rotterdam / NL
	02 / JANSSENS, Richard W. Erasmus Univ. Med.Ctr. R'Dam Dept. of Cell Biology & Genetics P.O. Box 1738 NL-3000 DR Rotterdam / NL
	03 / DRABEK, Dubravka Erasmus Univ. Med. Ctr. R'Dam Dept. of Cell Biology & Genetics P.O. Box 1738 NL-3000 DR Rotterdam / NL
	04 / CRAIG, Roger, Kingdon Jubilee House Farm, Spen Moss, Smallwood Sandbach, Cheshire CW11 2XB / GB
Representative(s)	Carpmaels & Ransford LLP, et al One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [2014/12]	Bullett, Rachel Margaret, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
Former [2009/51]	Mercer, Christopher Paul, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB
Former [2007/17]	Mercer, Christopher Paul, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB
Application number, filing date	05766644.8	22.07.2005
	[2007/17]
	WO2005GB02892
Priority number, date	GB20040016392	22.07.2004 Original published format: GB 0416392
	GB20050011881	10.06.2005 Original published format: GB 0511881
	[2007/17]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2006008548
	Date:	26.01.2006
	Language:	EN
	[2006/04]
	Type:	A2 Application without search report
	No.:	EP1776383
	Date:	25.04.2007
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 26.01.2006 takes the place of the publication of the European patent application.
	[2007/17]
	Type:	B1 Patent specification
	No.:	EP1776383
	Date:	20.08.2014
	Language:	EN
	[2014/34]
Search report(s)	International search report - published on:	EP	01.06.2006
Classification	IPC:	C07K16/00, A01K67/027, C12N5/10	[2007/17]
	CPC:	C07K16/241 (EP,US); C07K16/00 (EP,KR,US); A61K39/00 (GB); A01K67/027 (KR); A61K39/395 (GB); A61P1/00 (EP); (+) A61P11/06 (EP); A61P13/12 (EP); A61P15/00 (EP); A61P17/06 (EP); A61P19/02 (EP); A61P19/10 (EP); A61P25/00 (EP); A61P25/28 (EP); A61P3/04 (EP); A61P3/10 (EP); A61P31/04 (EP); A61P31/12 (EP); A61P31/18 (EP); A61P33/00 (EP); A61P35/00 (EP); A61P35/02 (EP); A61P37/00 (EP); A61P37/02 (EP); A61P37/04 (EP); A61P37/06 (EP); A61P7/02 (EP); A61P9/00 (EP); A61P9/10 (EP); A61P9/12 (EP); C07K16/1054 (EP,US); C07K16/1063 (EP,US); C07K16/1232 (EP,US); C07K16/30 (EP); C07K16/46 (GB); C12N15/62 (GB); C12N5/10 (KR); C07K2317/22 (EP,US); C07K2317/31 (EP,US); C07K2317/53 (EP,US); C07K2317/569 (EP,US); C07K2317/64 (EP,US); C07K2319/00 (EP,US); C07K2319/73 (EP) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/17]
Title	German:	BINDUNGSMOLEKÜLE	[2007/17]
	English:	BINDING MOLECULES	[2007/17]
	French:	MOLECULES DE LIAISON	[2007/17]
Entry into regional phase	22.02.2007	National basic fee paid
	22.02.2007	Designation fee(s) paid
	22.02.2007	Examination fee paid
Examination procedure	22.02.2007	Examination requested [2007/17]
	05.07.2007	Amendment by applicant (claims and/or description)
	31.07.2007	Despatch of a communication from the examining division (Time limit: M06)
	11.02.2008	Reply to a communication from the examining division
	15.08.2008	Observations by third parties
	29.12.2008	Despatch of a communication from the examining division (Time limit: M06)
	07.07.2009	Reply to a communication from the examining division
	01.02.2010	Observations by third parties
	08.11.2011	Despatch of a communication from the examining division (Time limit: M04)
	19.03.2012	Reply to a communication from the examining division
	20.03.2014	Date of oral proceedings
	27.03.2014	Minutes of oral proceedings despatched
	05.05.2014	Communication of intention to grant the patent
	13.05.2014	Observations by third parties
	04.06.2014	Fee for grant paid
	04.06.2014	Fee for publishing/printing paid
	04.06.2014	Receipt of the translation of the claim(s)
Divisional application(s)	EP07075586.3 / EP1864998
	EP08075481.5 / EP1978032
	EP10179784.3 / EP2311874
	EP17173113.6 / EP3272770
	EP23218163.6
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 31.07.2007
Opposition(s)	Opponent(s)	01 19.05.2015 28.05.2015 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB
		02 20.05.2015 01.06.2015 ADMISSIBLE Ablynx N.V. Technologiepark 21 9052 Ghent-Zwijnaarde / BE Opponent's representative Sanofi Patent Department 46 avenue de la Grande Armée 75017 Paris / FR
		03 20.05.2015 08.07.2015 WITHDRAWN Crescendo Biologics Limited Meditrina Building Babraham Research Campus Cambridge Cambridgeshire CB22 3AT / GB Opponent's representative Fleck, Barbara, et al, et al Marks & Clerk LLP 62-68 Hills Road Cambridge CB2 1LA / GB
		[N/P]
	Former [2020/03]
	Opponent(s)	01 19.05.2015 28.05.2015 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB
		02 20.05.2015 01.06.2015 ADMISSIBLE Ablynx N.V. Technologiepark 21 9052 Ghent-Zwijnaarde / BE Opponent's representative Sanofi 54, rue La Boétie 75008 Paris / FR
		03 20.05.2015 08.07.2015 WITHDRAWN Crescendo Biologics Limited Meditrina Building Babraham Research Campus Cambridge Cambridgeshire CB22 3AT / GB Opponent's representative Fleck, Barbara, et al, et al Marks & Clerk LLP 62-68 Hills Road Cambridge CB2 1LA / GB
	Former [2017/28]
	Opponent(s)	01 19.05.2015 28.05.2015 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
		02 20.05.2015 01.06.2015 ADMISSIBLE Ablynx N.V. Technologiepark 21 9052 Ghent-Zwijnaarde / BE Opponent's representative Kraft, Henricus Johannes Ablynx nv Technologiepark 21 9052 Zwijnaarde / BE
		03 20.05.2015 08.07.2015 WITHDRAWN Crescendo Biologics Limited Meditrina Building Babraham Research Campus Cambridge Cambridgeshire CB22 3AT / GB Opponent's representative Fleck, Barbara, et al, et al Marks & Clerk LLP 62-68 Hills Road Cambridge CB2 1LA / GB
	Former [2015/33]
	Opponent(s)	01 19.05.2015 28.05.2015 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Nicholls, James Ronald J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
		02 20.05.2015 01.06.2015 ADMISSIBLE Ablynx N.V. Technologiepark 21 9052 Ghent-Zwijnaarde / BE Opponent's representative Kraft, Henricus Johannes Ablynx nv Technologiepark 21 9052 Zwijnaarde / BE
		03 20.05.2015 08.07.2015 WITHDRAWN Crescendo Biologics Limited Meditrina Building Babraham Research Campus Cambridge Cambridgeshire CB22 3AT / GB Opponent's representative Fleck, Barbara, et al, et al Marks & Clerk LLP 62-68 Hills Road Cambridge CB2 1LA / GB
	Former [2015/30]
	Opponent(s)	01 19.05.2015 28.05.2015 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Nicholls, James Ronald J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
		02 20.05.2015 01.06.2015 ADMISSIBLE Ablynx N.V. Technologiepark 21 9052 Ghent-Zwijnaarde / BE Opponent's representative Kraft, Henricus Johannes Ablynx nv Technologiepark 21 9052 Zwijnaarde / BE
		03 20.05.2015 17.06.2015 ADMISSIBLE Crescendo Biologics Limited Meditrina Building Babraham Research Campus Cambridge Cambridgeshire CB22 3AT / GB Opponent's representative Fleck, Barbara, et al, et al Marks & Clerk LLP 62-68 Hills Road Cambridge CB2 1LA / GB
	Former [2015/27]
	Opponent(s)	01 19.05.2015 28.05.2015 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Nicholls, James Ronald J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
		02 20.05.2015 Ablynx N.V. Technologiepark 21 9052 Ghent-Zwijnaarde / BE Opponent's representative Kraft, Henricus Johannes Ablynx nv Technologiepark 21 9052 Zwijnaarde / BE
	Former [2015/26]
	Opponent(s)	01 19.05.2015 Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Nicholls, James Ronald J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
	deleted	Deletion: Legal effect of rejection of opposition [ N /P ]
	25.06.2015	Invitation to proprietor to file observations on the notice of opposition
	03.11.2015	Reply of patent proprietor to notice(s) of opposition
	17.11.2016	Date of oral proceedings
	22.12.2016	Despatch of minutes of oral proceedings
	22.12.2016	Date of despatch of rejection of opposition
	27.01.2022	Despatch of communication that the patent will be revoked
	05.02.2022	Legal effect of revocation of patent [2022/11]
Appeal following opposition	10.02.2017	Appeal received No. T0408/17
	28.04.2017	Statement of grounds filed
	26.01.2022	Result of appeal procedure: revocation of the patent
	27.01.2022	Despatch of the decision of the Board of Appeal
Fees paid	Renewal fee
	22.02.2007	Renewal fee patent year 03
	14.07.2008	Renewal fee patent year 04
	10.07.2009	Renewal fee patent year 05
	14.07.2010	Renewal fee patent year 06
	12.07.2011	Renewal fee patent year 07
	13.07.2012	Renewal fee patent year 08
	10.07.2013	Renewal fee patent year 09
	14.07.2014	Renewal fee patent year 10
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	deleted
	[2015/18]
Former [2015/12]	LV	20.08.2014
Cited in	International search	[Y]WO0212437 (SCHOOTEN WIM VAN [US], et al);
		[XDY]WO02085945 (UNIV ERASMUS [NL], et al);
		[XDY]WO02085944 (UNIV ERASMUS [NL], et al);
		[X]WO2004049794 (BABRAHAM INST [GB], et al);
	by applicant	US5487890
		WO02085945
		WO02085944
		US2003058074
		WO2004049794
		WO2003GB03319

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 35p